Chronic inflammatory demyelinating polyneuropathy accompanied by hepatocellular carcinoma.
We report a patient with chronic inflammatory demyelinating polyneuropathy (CIDP) accompanied by hepatocellular carcinoma (HCC). Due to the remarkable weakness in the lower limbs and loss of the position sense, he could not walk. On neurophysiological examination, he had impaired nerve conduction velocities. Biopsied nerve and muscle specimens demonstrated demyelination of nerve fibers and neurogenic degeneration of muscles. After steroid therapy he showed marked improvement in muscle strength and sensory function.
Sugai
F
F
Department of Neurology, Osaka University Medical School.
Abe
K
K
Fujimoto
T
T
Nagano
S
S
Fujimura
H
H
Kayanoki
Y
Y
Oshikawa
O
O
Yamasaki
E
E
Kawata
S
S
Matsuzawa
Y
Y
Yanagihara
T
T
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D006528:Carcinoma, Hepatocellular / Q000150:complications*; D003711:Demyelinating Diseases / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D009431:Neural Conduction / Q000187:drug effects; D010257:Paraneoplastic Syndromes / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D011115:Polyneuropathies / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology
D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone